Melatonin protects against oxidative stress in granular corneal dystrophy type 2 corneal fibroblasts by mechanisms that involve membrane melatonin receptors

Journal of Pineal Research

Volumn 51, Issue 1, 2011, Pages 94-103

  Choi, Seung Il ^a,b   Dadakhujaev, Shorafidinkhuja ^a,b   Ryu, Hyunmi ^a,b   Im Kim, Tae ^a,b   Kim, Eung Kweon ^a,b  

^a Cornea Dystrophy Research Institute ^*  (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

corneal fibroblasts; granular corneal dystrophy type 2; melatonin; melatonin receptors; oxidative stress

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE REDUCTASE; LUZINDOLE; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL DEATH; CELL DEGENERATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CORNEA DYSTROPHY; DEFENSE MECHANISM; ENZYME REGULATION; FIBROBLAST; GRANULAR CORNEAL DYSTROPHY TYPE 2; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PREMEDICATION; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR UPREGULATION; REGULATORY MECHANISM;

ANALYSIS OF VARIANCE; ANTIOXIDANTS; BLOTTING, WESTERN; CATALASE; CELL SURVIVAL; CELLS, CULTURED; CORNEA; CORNEAL DYSTROPHIES, HEREDITARY; FIBROBLASTS; FLOW CYTOMETRY; GLUTATHIONE REDUCTASE; HUMANS; HYDROGEN PEROXIDE; IMMUNOHISTOCHEMISTRY; MELATONIN; OXIDATIVE STRESS; PARAQUAT; REACTIVE OXYGEN SPECIES; RECEPTORS, MELATONIN; SUPEROXIDE DISMUTASE;

EID: 79960383133     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2011.00866.x     Document Type: Article

References (67)

1. Buddi R, Lin B, Atilano SR, et al., Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem 2002; 50: 341-351. (Pubitemid 34173022)
2. Wenk J, Brenneisen P, Meewes C, et al., UV-induced oxidative stress and photoaging. Curr Probl Dermatol 2001; 29: 83-94.
3. Shoham A, Hadziahmetovic M, Dunaief JL, et al., Oxidative stress in diseases of the human cornea. Free Radic Biol Med 2008; 45: 1047-1055.
4. Berlau J, Becker HH, Stave J, et al., Depth and age-dependent distribution of keratocytes in healthy human corneas: a study using scanning-slit confocal microscopy in vivo. J Cataract Refract Surg 2002; 28: 611-616. (Pubitemid 34286779)
5. Finkel T, Holbrook NJ,. Oxidants, oxidative stress and the biology of ageing. Nature 2000; 408: 239-247.
6. Halliwell B,. Free radicals and antioxidants: a personal view. Nutr Rev 1994; 52: 253-265. (Pubitemid 24308025)
7. Sies H, Stahl W,. Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 1995; 62: 1315S-1321S.
8. Rao NA,. Role of oxygen free radicals in retinal damage associated with experimental uveitis. Trans Am Ophthalmol Soc 1990; 88: 797-850.
9. Franco A, Odom R, Rando T,. Regulation of antioxidant enzyme gene expression in response to oxidative stress and during differentiation of mouse skeletal muscle. Free Radic Biol Med Free 1999; 27: 1122-1132. (Pubitemid 29507485)
10. Pahl H, Baeuerle P,. Oxygen and the control of gene expression. Bioessays 1994; 16: 497-502.
11. Ceballos-Picot I, Nicole A, Clement M, et al., Age-related changes in antioxidant enzymes and lipid peroxidation in brains of control and transgenic mice overexpressing copper-zinc superoxide dismutase. Mutat Res 1992; 275: 281-293.
12. Mauriz JL, Molpeceres V, Garcia-Mediavilla MV, et al., Melatonin prevents oxidative stress and changes in antioxidant enzyme expression and activity in the liver of aging rats. J Pineal Res 2007; 42: 222-230. (Pubitemid 46365058)
13. Klintworth GK,. Advances in the molecular genetics of corneal dystrophies. Am J Ophthalmol 1999; 128: 747-754. (Pubitemid 30001771)
14. Skonier J, Neubauer M, Madisen L, et al., cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol 1992; 11: 511-522.
15. Korvatska E, Henry H, Mashima Y, et al., Amyloid and non-amyloid forms of 5q31-linked corneal dystrophy resulting from kerato-epithelin mutations at Arg-124 are associated with abnormal turnover of the protein. J Biol Chem 2000; 275: 11465-11469. (Pubitemid 30212801)
16. Choi SI, Kim TI, Kim KS, et al., Decreased catalase expression and increased susceptibility to oxidative stress in primary cultured corneal fibroblasts from patients with granular corneal dystrophy type II. Am J Pathol 2009; 175: 248-261.
17. Reiter RJ,. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12: 151.
18. Dominguez-Rodriguez A, Abreu-Gonzalez P, Sanchez-Sanchez JJ, et al., Melatonin and circadian biology in human cardiovascular disease. J Pineal Res 2010; 49: 14-22.
19. Hoppe JB, Frozza RL, Horn AP, et al., Amyloid-beta neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3beta, tau and neuroinflammation. J Pineal Res 2010; 48: 230-238.
20. Jung-Hynes B, Reiter RJ, Ahmad N,. Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J Pineal Res 2010; 48: 9-19.
21. Girgert R, Hanf V, Emons G, et al., Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells. J Pineal Res 2009; 47: 23-31.
22. Bejarano I, Redondo PC, Espino J, et al., Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells. J Pineal Res 2009; 46: 392-400.
23. Tan D, Chen L, Poeggeler B, et al., Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
24. Allegra M, Reiter RJ, Tan DX, et al., The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003; 34: 1-10. (Pubitemid 36140351)
25. Hardeland R, Tan DX, Reiter RJ,. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47: 109-126.
26. Ressmeyer AR, Mayo JC, Zelosko V, et al., Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. Redox Rep 2003; 8: 205-213. (Pubitemid 37236233)
27. Rodriguez C, Mayo JC, Sainz RM, et al., Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9. (Pubitemid 38130283)
28. Pablos MI, Agapito MT, Gutierrez R, et al., Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks. J Pineal Res 1995; 19: 111-115.
29. Sun FY, Lin X, Mao LZ, et al., Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia. J Pineal Res 2002; 33: 48-56. (Pubitemid 34833074)
30. Yoo YM, Yim SV, Kim SS, et al., Melatonin suppresses NO-induced apoptosis via induction of Bcl-2 expression in PGT-beta immortalized pineal cells. J Pineal Res 2002; 33: 146-150.
31. Jou MJ, Peng TI, Hsu LF, et al., Visualization of melatonin's multiple mitochondrial levels of protection against mitochondrial Ca(2+)-mediated permeability transition and beyond in rat brain astrocytes. J Pineal Res 2010; 48: 20-38.
32. Paradies G, Petrosillo G, Paradies V, et al., Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 2010; 48: 297-310.
33. Choi SI, Joo SS, Yoo YM,. Melatonin prevents nitric oxide-induced apoptosis by increasing the interaction between 14-3-3beta and p-Bad in SK-N-MC cells. J Pineal Res 2008; 44: 95-100.
34. Brydon L, Barrett P, Morgan PJ, et al., Investigation of the human Mel 1a melatonin receptor using anti-receptor antibodies. Adv Exp Med Biol 1999; 460: 215-220.
35. Dubocovich ML, Masana MI, Benloucif S,. Molecular pharmacology and function of melatonin receptor subtypes. Adv Exp Med Biol 1999; 460: 181-190.
36. Rada JA, Wiechmann AF,. Melatonin receptors in chick ocular tissues: implications for a role of melatonin in ocular growth regulation. Invest Ophthalmol Vis Sci 2006; 47: 25-33. (Pubitemid 46780791)
37. Meyer P, Pache M, Loeffler KU, et al., Melatonin MT-1-receptor immunoreactivity in the human eye. Br J Ophthalmol 2002; 86: 1053-1057. (Pubitemid 34953623)
38. Siu AW, Maldonado MD, Sanchez-Hidalgo M, et al., Protective effects of melatonin in experimental free radical-related ocular diseases. J Pineal Res 2006; 40: 101-109.
39. Rosenstein RE, Pandi-Perumal SR, Srinivasan V, et al., Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis. J Pineal Res 2010; 49: 1-13.
40. Yi C, Pan X, Yan H, et al., Effects of melatonin in age-related macular degeneration. Ann N Y Acad Sci 2005; 1057: 384-392. (Pubitemid 43211648)
41. Sanchez-Barcelo EJ, Mediavilla MD, Tan DX, et al., Clinical uses of melatonin: evaluation of human trials. Curr Med Chem 2010; 17: 2070-2095.
42. Nava F, Calapai G, Facciola G, et al., Melatonin effects on inhibition of thirst and fever induced by lipopolysaccharide in rat. Eur J Pharmacol 1997; 331: 267-274. (Pubitemid 27331459)
43. Behan WM, Mcdonald M, Darlington LG, et al., Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br J Pharmacol 1999; 128: 1754-1760. (Pubitemid 30011889)
44. Pablos MI, Guerrero JM, Ortiz GG, et al., Both melatonin and a putative nuclear melatonin receptor agonist CGP 52608 stimulate glutathione peroxidase and glutathione reductase activities in mouse brain in vivo. Int J Prenat Perinat Psychol Med 1997; 9: 441-447. (Pubitemid 128026548)
45. Holliman BJ, Chyka PA,. Problems in assessment of acute melatonin overdose. South Med J 1997; 90: 451-453. (Pubitemid 27176415)
46. Reiter RJ,. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998; 56: 359-384. (Pubitemid 28389724)
47. Tan DX, Reiter RJ, Manchester LC, et al., Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002; 2: 181-197.
48. Winiarska K, Fraczyk T, Malinska D, et al., Melatonin attenuates diabetes-induced oxidative stress in rabbits. J Pineal Res 2006; 40: 168-176.
49. Baydas G, Canatan H, Turkoglu A,. Comparative analysis of the protective effects of melatonin and vitamin E on streptozocin-induced diabetes mellitus. J Pineal Res 2002; 32: 225-230. (Pubitemid 34478283)
50. Montilla P, Cruz A, Padillo FJ, et al., Melatonin versus vitamin E as protective treatment against oxidative stress after extra-hepatic bile duct ligation in rats. J Pineal Res 2001; 31: 138-144. (Pubitemid 32778162)
51. Hsu C, Han B, Liu M, et al., Phosphine-induced oxidative damage in rats: attenuation by melatonin. Free Radic Biol Med 2000; 28: 636-642. (Pubitemid 30136045)
52. Rosales-Corral S, Tan DX, Reiter RJ, et al., Orally administered melatonin reduces oxidative stress and proinflammatory cytokines induced by amyloid-beta peptide in rat brain: a comparative, in vivo study versus vitamin C and E. J Pineal Res 2003; 35: 80-84. (Pubitemid 36960345)
53. Anwar MM, Meki AR,. Oxidative stress in streptozotocin-induced diabetic rats: effects of garlic oil and melatonin. Comp Biochem Physiol A Mol Integr Physiol 2003; 135: 539-547. (Pubitemid 37289114)
54. Costa EJ, Lopes RH, Lamy-Freund MT,. Permeability of pure lipid bilayers to melatonin. J Pineal Res 1995; 19: 123-126.
55. Shida CS, Castrucci AM, Lamy-Freund MT,. High melatonin solubility in aqueous medium. J Pineal Res 1994; 16: 198-201.
56. Tan D, Reiter RJ, Chen LD, et al., Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 1994; 15: 215-218. (Pubitemid 24121651)
57. Abe M, Reiter RJ, Orhii PB, et al., Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin. J Pineal Res 1994; 17: 94-100.
58. Melchiorri D, Reiter RJ, Attia AM, et al., Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci 1995; 56: 83-89. (Pubitemid 24380187)
59. Montilla-Lopez P, Munoz-Agueda MC, Feijoo Lopez M, et al., Comparison of melatonin versus vitamin C on oxidative stress and antioxidant enzyme activity in Alzheimer's disease induced by okadaic acid in neuroblastoma cells. Eur J Pharmacol 2002; 451: 237-243. (Pubitemid 35254026)
60. Kotler M, Rodriguez C, Sainz RM, et al., Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res 1998; 24: 83-89. (Pubitemid 28168319)
61. Zwirska-Korczala K, Jochem J, Adamczyk-Sowa M, et al., Influence of melatonin on cell proliferation, antioxidative enzyme activities and lipid peroxidation in 3T3-L1 preadipocytes - an in vitro study. J Physiol Pharmacol 2005; 56 (Suppl 6): 91-99. (Pubitemid 43120946)
62. Yu L, Wan F, Dutta S, et al., Autophagic programmed cell death by selective catalase degradation. Proc Natl Acad Sci U S A 2006; 103: 4952-4957.
63. Hassan HM,. Biosynthesis and regulation of superoxide dismutases. Free Radic Biol Med 1988; 5: 377-385.
64. Marklund SL, Oreland L, Perdahl E, et al., Superoxide dismutase activity in brains from chronic alcoholics. Drug Alcohol Depend 1983; 12: 209-215. (Pubitemid 14249808)
65. Barlow-Walden LR, Reiter RJ, Abe M, et al., Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 1995; 26: 497-502.
66. Uyama O, Matsuyama T, Michishita H, et al., Protective effects of human recombinant superoxide dismutase on transient ischemic injury of CA1 neurons in gerbils. Stroke 1992; 23: 75-81.
67. Kinouchi H, Epstein CJ, Mizui T, et al., Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc Natl Acad Sci U S A 1991; 88: 11158-11162. (Pubitemid 21915999)